BioSpace News Archive

Press Releases

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

September 23, 2025
·
12 min read
Press Releases

European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®

September 23, 2025
·
9 min read
Press Releases

Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies Demonstrated a Significant Improvement in Minimal Residual Disease Negativity Rates in Relapsed or Refractory Multiple Myeloma

September 23, 2025
·
6 min read
Press Releases

Drug Farm Announces Agreement with Cincinnati Children’s Hospital Medical Center to Explore ALPK1 Inhibitor, DF-003 as a Potential Treatment for Heart Disease and Blood Cancers Driven by Clonal Hematopoiesis

September 23, 2025
·
3 min read
Press Releases

Kayothera, Inc. Nominates KAYO-1732, a First-In-Class, Oral Inhibitor of the Retinoid Nuclear Receptor Pathway in Type 2 Diabetes and Cardiometabolic Indications as a Development Candidate

September 23, 2025
·
2 min read
Press Releases

Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language

September 23, 2025
·
7 min read
Press Releases

Virtuoso Surgical Robotic System Receives FDA Breakthrough Device Designation

September 23, 2025
·
4 min read
Press Releases

AbTherx and Dragonfly Therapeutics Expand Antibody Discovery Partnership

September 23, 2025
·
3 min read
Press Releases

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 2025

September 23, 2025
·
8 min read
Press Releases

Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay

September 23, 2025
·
7 min read